Cite

HARVARD Citation

    Imyanitov, E. et al. (n.d.). 1395PLung cancers carrying distinct ALK fusion variants demonstrate similar responsiveness to ALK tyrosine kinase inhibitors. Annals of oncology. p. . [Online]. 
  
Back to record